As shown in Figure 1A, 22 of 44 (50.0%) cases showed significant upregulation of DNMT1 in HCC, 22 of 44 (50.0%) cases showed no alteration or reduction. This evidence concerns the gene DNMT1 and hepatocellular carcinoma.